To study the clinical relevance of tumor ploidy and micronucleus formation as prognostic factors.
Methods and Study Design
Twenty-eight patients with squamous cell carcinoma of the oral cavity were treated with primary radiochemotherapy consisting of irradiation up to 70 Gy in combination with cisplatin. Cell cycle distribution, micronucleus formation and ploidy were evaluated by flow cytometry of biopsies taken before treatment and after irradiation to 10 Gy (5 × 2 Gy). Sexteen out of 28 patients relapsed after a minimum follow-up period of two years.
Results
Flow cytometry of the recurrence biopsy showed hyperpentaploid (5c exceeding) cells in 13/16 (81%) of the relapsed patients. In 7 patients the hyperploid clone was not present in the flow cytometry of the primary tumors. Ploidy could retrospectively be determined also by image cytometry in archival tumor material of the pretreatment specimens. Patients with a level below 100 5c cells per 10,000 cell nuclei were shown to have a significantly better prognosis than patients with more than 100 hyperpentaploid tumor cells. The micronucleus formation was 2-5 times higher in tumors showing a good response to treatment than in carcinomas relapsing within two years.
Conclusions
The 5c-exceeding ratio measured by image cytometry and micronucleus formation proved to be good prognostic parameters for the clinical outcome of patients with locally advanced head and neck carcinomas.
BenettM.H., WilsonG.D., DisheS., SaundersM.I., MartindaleCA., RobinsonB.M., O'HoloranA.E., LeslieM.D., LaingJ.H.: Tumour proliferation assessed by combined histological and flow cytometric analysis: implications of therapy in squamous cell carcinomas of head and neck.Br. J. Cancer, 65: 870–878, 1992.
2.
BhattathiriV.N., BinduL., RemaniP., ChandralekhaB., DavisC.A., Krishnan NairM.: Serial cytological assay of micronucleus induction: a new tool to predict human cancer radiosensitivity.Radiother. Oncol., 41: 139–142, 1996.
3.
BushT., McMillanT.J.: Micronucleus formation in human tumour cells: lack of correlation with radiosensitivity.Br. J. Cancer, 67: 102–106, 1993.
4.
ChampionA.R., HansonJ.A., VenablesS.E., McGregorA.D., GaffneyC.C.: Determination of radiosensitivity in established and primary squamous cell carcinoma cultures using the micronucleus assay.Eur. J. Cancer, 33: 453–462, 1997.
5.
CountrymanP.I., HeddleJ.A.: The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes.Mutat. Res., 41: 321–332, 1971.
6.
DahlhäuserS., StrehlH., ZamboglouN.: Radiosensitivity of hyperpentaploid cell clones in carcinoma of the vulva.Strahlenther. Onkol., 171: 94–99, 1995.
7.
DischeS., SaundersM.I.: The rationale for continuous hyper-fractionated radiotherapy (CHART).Int. J. Radiat. Oncol. Biol. Phys., 19: 1317–1320, 1990.
8.
van Driel-KulkerA.M.J., PloemJ.S.: The use of LEYTAS in analytical and quantitative cytology.IEEE Trans. Biomed. Eng., BME-29, 2: 92–100, 1982.
9.
van Driel-KulkerA.M.J., MeskerW.E., van VelzenI., TankeH.J., FeichtigerJ., PloemJ.S.: Preparation of monolayer smears from paraffin-embebbed tissue for image cytometry.Cytometry, 6: 268–272, 1985.
10.
EnsleyJ., MaciorowskiZ., PietraszkiewiczH., KishJ., TapazoglouE., JakobsJ., MathogR., SakrW., Al SaraffM., MetchB., SchullerD., ColtmanC.: Prospective correlation of cytotoxic response and DNA content parameters in advanced squamous cell cancer of the head and neck.Proc. ASCO, 9: 173, 1990.
11.
GustafsonH., TribukaitB., EspostiP.L.: DNA profile and tumour progession in patients with superficial bladder tumours.Urol. Res., 10: 13, 1982.
12.
HeddleJ.A.: A rapid in vivo test for chromosomal damage.Mutat. Res., 18: 187–190, 1973.
13.
HogstedtB., KarlssonA.: The size of micronuclei in human lymphocytes varies according to inducing agent used.Mutat. Res., 156: 229–232, 1985.
14.
JohnsonT.S., KennethD., WilliamsonD., CramerM.M., LesterJ.E.: Flow cytometric analysis of head and neck carcinoma, DNA index and S-fraction from paraffin embedded sections: comparison with malignacy grading.Cytometry, 6: 461–470, 1985.
15.
KorenageD., OkamuraT., SaitoA., BabaH., SugimachiK.: DNA ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosis in clinical gastric cancer.Cancer, 62: 309–313, 1988.
16.
LjungbergB., StenlingB., RoosG.: DNA content and prognosis in renal cell carcinoma.Cancer, 57: 2346–2350, 1986.
17.
MidanderJ., ReveszL.: The frequency of micronuclei as a measure of cell survival in irradiated cell populations.Int. J. Radiat. Oncol. Biol. Phys., 38: 237–242, 1980.
18.
MollsM., SackH., StrefferC., PelzerT., MohrC., SchettlerD.: DNA content, S-fraction and micronucleus formation. Prognostic significance in oral cavity cancer. In: Progress in radio-oncology IV, KärcherK.H. (Ed.), pp. 149–152, ICRO, Vienna, 1988.
SchabronathJ., StrefferC., ZamboglouN.: Cytofluorometric determination of protein-bound thiols and DNA in cell nuclei.Cytometry, 11: 333–340, 1990.
21.
StrefferC., van BeuningenD., MollsM., ZamboglouN.: How relevant is the labelling index for cell proliferation?Br. J. Cancer, 41(suppl. IV): 205, 1980.
22.
StrefferC., van BeuningenD., BambergM., EiglerF.W., GrossE., SchabronathJ.: An approach to the individualization of cancer therapy determination of DNA, SH-groups and micronuclei.Strahlentherapie, 160: 661–666, 1984.
23.
StrefferC., van BeuningenD., GrossE., SchabronathJ., EiglerF.W., RebmannA.: Predictive assays for the therapy of rectum carcinoma.Radiother. Oncol., 5: 303–310, 1986.
24.
TankeH.J., BrusseeJ.A.M., van Driel-KulkerA.M.J., van der BurgM.J., Schelvis-KnepfleC.F.H.M., JonasU., PloemJ.S.: Results of the automated analysis of 328 bladder specimens using the Leyden television analysis system (LEYTAS).World J. Urol., 1: 77–81, 1983.
25.
TribukaitB., GustafsonH., EspostiP.L.: Ploidy proliferation in human bladder tumours as measured by flowcytometric DNA analysis and its relation to histopathology and cytology.Cancer, 43: 1742, 1973.
26.
VillaR., ZaffaroniR., GornatilD., CostaA., SilvestriniC.: Lack of a correlation between micronucleus formation and radiosensitivity in established and primary cultures of human tumours.Br. J. Cancer, 70: 1112–1117, 1994.
27.
WandlE.O., OnoK., KainR., HerbsthoferT., HienertG., HobarthK.: Linear correlation between surviving fraction and the micronucleus frequency.Int. J. Radiat. Biol., 56: 771–775, 1989.
28.
YuJ.M., YangL.H., Guo-Qian, ChenY.T., LiX., ZhongW.X., ChenY.C., TianG.D.: Flow cytometric analysis DNA content in esophageal carcinoma.Cancer, 64: 80–82, 1989.
29.
YuJ.M., ZhangH., WangS.Q., MiaoH.Q., YangL.H., ChenY.T., TianG.D.: DNA ploidy analysis of effectiveness of radiation therapy for cervical carcinoma.Cancer, 68: 76–78, 1991.
30.
ZölzerF., AlbertiW., PelzerT., LambertiG., HülskampF.H., StrefferC.: Changes in S-phase fraction and micronucleus frequency as prognostic factors in radiotherapy of cervical carcinoma.Radiother. Oncol., 36: 128–132, 1995.
